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Purpose/Objective: Planning and executing a HDR (High Dose 
Rate) intracavitary brachytherapy treatment for cervical 
carcinoma can involve several patient bed transfers. In the 
current study, patients have to be moved twice, and undergo 
four bed transfers which can imply a cylinder dislocation 
from its initial position immediately after the cylinder 
implant. This study aims to quantify the cylinder 
displacement due to patient manipulation after the initial 
implant position, at CT scan acquisition moment and during 
treatment. 
Materials and Methods: Nineteen patients were included in 
this study. The patients underwent three fractions of 
intracavitary brachytherapy using vaginal cylinders with 
diameters ranging from 20 mm to 40 mm. In the first session, 
after cylinder positioning, two orthogonal x-rays (antero-
posterior and lateral) are acquired. Then the patient is 
transported to the CT room for treatment planning image 
acquisition. At last, the patient is carried to the treatment 
room, where two additional x-ray images, in the same 
conditions as after the implant, are also acquired. The 
treatment dose is prescribed at a point located 0.5 cm from 
the cylinder wall and the treated extension is 3 cm. The 
deviations of the applicator caused by the movement of the 
patient were assessed with regard to distances and angles 
between fixed points on the cylinder and the bony structure 
of the patient. The evaluated parameters were: A) the 
distance between the lower ring of the cylinder and the 
superior limit of the pubic symphysis (point 'x' in Figure 1A); 
B) the angle formed by two straight lines that start at the 
intersection of the central axis of the cylinder with the 
superior limit of the pubic symphysis (angle 'α' in Figure 1B) 
extending to the upper ring (point 'a' in Figure 1B) and the 
other to the supero-lateral limit of obturator foramen (point 
'b' in Figure 1B); and C) distances between the treatment 
couch and the central axis on the upper and lower rings 
(points 'y1' and 'y2' in Figure 1C). 
 
 
Results: The observed geometrical deviations of the vaginal 
cylinders from its initial position varied as follows: 'x' varied 
from 0 cm to 1.4 cm with an average of 0.39 cm (SD = 0.36 
cm); 'α' from 0.06º to 6.53º, with and average of 1.93º (SD = 
1.61 cm). Measurements of y1 and y2 could not be evaluated 
due to large geometric uncertainty. 
Conclusions: Although the maximum deviation of 'x' exceeds 
the prescription depth, the dose delivered to the vaginal 
mucosa is equal, since this tissue is elastic and follows the 
cylinder movement. Nevertheless, undetermined 
consequences on the dose distribution in organs at risk might 
arise. The evaluation of the dose uncertainty at healthy 
tissues will be assessed in a future development of this work.  
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Purpose/Objective: In the multidisciplinary therapy era for 
high risk prostate cancer, external beam radiation therapy is 
often combined with brachytherapy boost. We have 
investigated the impact of implanted seeds on dose 
distributions for prostate VMAT by way of Monte Carlo 
calculation and film measurement. 
Materials and Methods: Iodine-125 seeds, OncoSeed (Oncura, 
USA), were implanted into a prostate training phantom for 
brachytherapy, Model 053 (CIRS, USA), and the phantom was 
positioned in water with an acrylic enclosure. VMAT plans for 
the prostate phantom with and without the seeds were 
created by a Monte Carlo based TPS, Monaco (Elekta, 
Sweden) and the dose distributions were calculated. Another 
Monte Carlo code, EGSnrc, was also employed to compare 
calculated dose distributions. Radiochromic films were also 
used to measure dose distributions inside the phantom. 
Results: It was observed that the calculated dose differences 
with and without the seeds using either Monaco or EGSnrc 
were negligibly small. It was further confirmed that the 
measured dose differences with and without the seeds were 
also insignificant. These results suggested that the VMAT 
beams from multiple directions may compensate any small 
dose perturbation by way of spatial averaging. 
Conclusions: We observed that the impact of brachytherapy 
seeds on prostate VMAT dose delivery may be insignificant, 
thereby encouraging a use of seeds for brachytherapy 
followed by prostate VMAT.  
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Purpose/Objective: To look retrospectively at the effects in 
needle number and post-implant doses of increasing the 
activity of the seeds used in prostate implants from 
0.356mCi-0.369mCi to 0.536mCi-0.555mCi. CT scans after 
implants are used to find prostate, rectum and bladder doses 
indicative of dosimetric coverage and dose to organs at risk. 
The aim of this work is to assess whether the use of higher 
activity seeds reduces needle related trauma can be reduced 
whilst maintaining adequate coverage as well as maintaining 
adequate OAR sparing.  
Materials and Methods: Patients with prostate volumes over 
40cc with associated post-implant data (6 weeks post 
treatment) were included in the study. A mean value and 
range is found for the needle number and post implant 
dosimetric parameters. All patients were planned with the 
same dose constraints with regards to prostate coverage and 
OAR sparing.  
